Mephenytoin
- Generic Name
- Mephenytoin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H14N2O2
- CAS Number
- 50-12-4
- Unique Ingredient Identifier
- R420KW629U
- Background
Mephenytoin is used for the treatment of refractory partial epilepsy. Mephenytoin is a solid. This compound belongs to the phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. Mephenytoin is known to target sodium channel protein type 5 subunit alpha. Cytochrome P450 2C19, Cytochrom...
- Indication
For the treatment of refractory partial epilepsy.
- Associated Conditions
- -
- Associated Therapies
- -
Metabolic Capacity of Israeli Populations
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 1200
- Registration Number
- NCT00162383
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath